A New Multimodal Treatment Approach for Children With Spastic Diplegic Cerebral Palsy

NCT ID: NCT05504798

Last Updated: 2023-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-01

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Combining the advantages of both Neuromuscular electrical stimulation and lower limb serial casting to a selected physical therapy program in children with spastic diplegic cerebral palsy to overcome the adverse effects during the period of casting and the long period of rehabilitative interventions, providing a new multimodal treatment approach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spastic Diplegic Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group (A)

will receive a selected physical therapy program.

Group Type ACTIVE_COMPARATOR

Selected physical therapy program

Intervention Type OTHER

Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.

Group (B)

will receive interrupted progressive serial casting in addition to a modified selected physical therapy program during casting.

Group Type ACTIVE_COMPARATOR

Selected physical therapy program

Intervention Type OTHER

Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.

Interrupted serial casting

Intervention Type PROCEDURE

Interrupted casting for 5 days a week for six successive weeks using a dual cast which consists of a standard short leg cast and a circular cast from below the knee to above the knee.

Group (C)

will receive interrupted progressive serial casting and the modified selected physical therapy as group (B) in addition to neuromuscular electrical stimulation for ankle dorsiflexors and knee extensors muscles through cast windows

Group Type ACTIVE_COMPARATOR

Selected physical therapy program

Intervention Type OTHER

Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.

Interrupted serial casting

Intervention Type PROCEDURE

Interrupted casting for 5 days a week for six successive weeks using a dual cast which consists of a standard short leg cast and a circular cast from below the knee to above the knee.

Neuromuscular electrical stimulation

Intervention Type DEVICE

Neuromuscular electrical stimulation in form of faradic current with frequency of 50 Hz, and intensity of maximum tolerable intensity to produce a visible contraction but as tolerated by the child for ankle dorsiflexors and knee extensors muscles through cast windows over the motor points of these muscles for 30 min 3 times weekly for six successive weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Selected physical therapy program

Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.

Intervention Type OTHER

Interrupted serial casting

Interrupted casting for 5 days a week for six successive weeks using a dual cast which consists of a standard short leg cast and a circular cast from below the knee to above the knee.

Intervention Type PROCEDURE

Neuromuscular electrical stimulation

Neuromuscular electrical stimulation in form of faradic current with frequency of 50 Hz, and intensity of maximum tolerable intensity to produce a visible contraction but as tolerated by the child for ankle dorsiflexors and knee extensors muscles through cast windows over the motor points of these muscles for 30 min 3 times weekly for six successive weeks

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The children will have grade 2 or 3 on Modified Ashworth Scale.
* The children will have Level II, or III according to the Gross Motor Function Classification System.
* The children walk with equinus or jump gait patterns with spasticity of the hamstrings and hip flexors in addition to calf muscles spasticity.
* Children take their Antispastic drug use such as baclofen, diazepam or tizanidine.
* All children will be able to follow instructions.

Exclusion Criteria

* children will be excluded from the study if they have any problems of the following:

* Cognitive dysfunction.
* Poor skin integrity.
* History of or recent nonunion fracture.
* Fixed contractures and deformities.
* Previous surgery (tendon lengthening).
* Received Botulinum toxin A injections in the last six months.
* Impaired circulation.
Minimum Eligible Age

3 Years

Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yasser Mamdouh Abd Elmonem Mohamed

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yasser M Abd Elmonem, MSC

Role: CONTACT

+201099259395

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yasser M Abd Elmonem, MSC

Role: primary

+201099259395

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/003675

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.